Rockefeller Capital Management’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.81M | Buy |
11,811
+294
| +3% | +$45.1K | ﹤0.01% | 1143 |
|
|
2025
Q1 | $1.81M | Hold |
11,517
| – | – | ﹤0.01% | 1075 |
|
|
2024
Q4 | $1.81M | Hold |
11,517
| – | – | ﹤0.01% | 1046 |
|
|
2024
Q3 | $2.04M | Hold |
11,517
| – | – | 0.01% | 985 |
|
|
2024
Q2 | $1.94M | Hold |
11,517
| – | – | 0.01% | 984 |
|
|
2024
Q1 | $1.92M | Buy |
11,517
+25
| +0.2% | +$4.16K | 0.01% | 1021 |
|
|
2023
Q4 | $1.9M | Hold |
11,492
| – | – | 0.01% | 933 |
|
|
2023
Q3 | $1.79M | Sell |
11,492
-298
| -3% | -$46.4K | 0.01% | 885 |
|
|
2023
Q2 | $1.84M | Buy |
11,790
+298
| +3% | +$46.5K | 0.01% | 876 |
|
|
2023
Q1 | $1.86M | Sell |
11,492
-230
| -2% | -$37.3K | 0.01% | 839 |
|
|
2022
Q4 | $1.87M | Buy |
11,722
+230
| +2% | +$36.7K | 0.01% | 771 |
|
|
2022
Q3 | $1.62M | Buy |
11,492
+100
| +0.9% | +$14.1K | 0.01% | 835 |
|
|
2022
Q2 | $1.66M | Hold |
11,392
| – | – | 0.01% | 825 |
|
|
2022
Q1 | $1.85M | Hold |
11,392
| – | – | 0.01% | 824 |
|
|
2021
Q4 | $2.16M | Hold |
11,392
| – | – | 0.01% | 769 |
|
|
2021
Q3 | $2.3M | Hold |
11,392
| – | – | 0.01% | 718 |
|
|
2021
Q2 | $2.3M | Hold |
11,392
| – | – | 0.01% | 686 |
|
|
2021
Q1 | $2M | Hold |
11,392
| – | – | 0.01% | 577 |
|
|
2020
Q4 | $1.93M | Hold |
11,392
| – | – | 0.01% | 525 |
|
|
2020
Q3 | $1.85M | Hold |
11,392
| – | – | 0.02% | 451 |
|
|
2020
Q2 | $1.86M | Hold |
11,392
| – | – | 0.02% | 409 |
|
|
2020
Q1 | $1.46M | Buy |
11,392
+42
| +0.4% | +$5.38K | 0.02% | 399 |
|
|
2019
Q4 | $1.58M | Buy |
11,350
+10
| +0.1% | +$1.39K | 0.02% | 384 |
|
|
2019
Q3 | $1.34M | Hold |
11,340
| – | – | 0.02% | 345 |
|
|
2019
Q2 | $1.46M | Hold |
11,340
| – | – | 0.02% | 293 |
|
|
2019
Q1 | $1.46M | Hold |
11,340
| – | – | 0.02% | 310 |
|
|
2018
Q4 | $1.26M | Buy |
+11,340
| New | +$1.26M | 0.02% | 221 |
|